Level A· Stronger Clinical EvidenceMeta-analysisEurope PMCOpen access

The relationship between metabolic syndrome and environmental endocrine disruptors: A systematic review and meta-analysis

Pan K., Xu J., Li F., Aris AZ., Yu H., Xu Y.

Meta-analysis on Hip, published in iScience (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Meta-analysis
Journal
iScience (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40687822
PMCID
PMC12270799
DOI
10.1016/j.isci.2025.112907
Citations
1

Abstract (original English)

Metabolic syndrome (MetS) is considered to be an important factor leading to an increased risk of chronic non-communicable diseases. Studies have found that exposure to environmental endocrine disruptors (EEDs) is associated with MetS, but the relationship between the two is unclear. In order to clarify the relationship between the two, a systematic review and meta-analysis were conducted to investigate their association. We searched Web of Science databases, Embase, and PubMed. We then utilized I 2 statistics to assess the literature heterogeneity and pooled the data using both fixed-effects model (I 2 2 > 50%) in accordance with the PRISMA guidelines. The results showed that exposure to perfluoroalkyl substances (PFASs) was associated to specific components of MetS, such as PFNA and "high waist circumference" (OR = 1.23, 95% CI: 1.10-1.38), and PFOA and "elevated blood pressure" (OR = 1.05, 95% CI: 1.01-1.08). Exposure to phthalates (PAEs) increases the risk of MetS, with MECPP (OR = 1.16, 95% CI: 1.04-1.29) being an example. Moreover, polychlorinated biphenyls (PCBs) (OR = 1.47, 95% CI: 1.13-1.93) and organochlorine pesticides (OCPs) (OR = 1.97, 95% CI: 1.33-2.90) showed a positive association with the MetS. This study reveals that EEDs are a risk factor for MetS, which provides new evidence for the relationship between population EEDs exposure and MetS.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research